Downregulation of RCAS1 and upregulation of cytotoxic T cells affects synovial proliferation and apoptosis in rheumatoid arthritis

Journal of Rheumatology

Volumn 35, Issue 9, 2008, Pages 1716-1722

  Yoshida, Shiro ^a   Higuchi, Fujio ^a,b   Ishibashi, Yumiko ^a,b   Goto, Masafumi ^a,b   Sugita, Yasuo ^a   Nomura, Yuko ^a   Karube, Kennosuke ^a   Shimizu, Kei ^a   Aoki, Ryosuke ^a   Komatani, Hideki ^a   Hashikawa, Keiko ^a   Kimura, Yoshizo ^a   Nakashima, Manabu ^c   Nagata, Kensei ^a   Ohshima, Koichi ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Medical Center   (United States)

^c FUKUOKA UNIVERSITY   (Japan)

Author keywords

Apoptosis; Caspase 3; Foxp3; Ki 67; Proliferation; RCAS1; Rheumatoid arthritis; Synovium

Indexed keywords

C REACTIVE PROTEIN; CASPASE 3; KI 67 ANTIGEN; MARKER; RECEPTOR BINDING CANCER ANTIGEN EXPRESSED ON SISO CELLS; TRANSCRIPTION FACTOR FOXP3; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DOWN REGULATION; GERMINAL CENTER; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC INFILTRATION; OSTEOARTHRITIS; PRIORITY JOURNAL; RECEPTOR BINDING; REGULATORY T LYMPHOCYTE; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; SYNOVIUM; UPREGULATION;

ANTIGENS, NEOPLASM; APOPTOSIS; ARTHRITIS, RHEUMATOID; C-REACTIVE PROTEIN; CASPASE 3; CELL PROLIFERATION; DOWN-REGULATION; FORKHEAD TRANSCRIPTION FACTORS; GERMINAL CENTER; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; SYNOVIAL MEMBRANE; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, REGULATORY; UP-REGULATION;

EID: 54049090085     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Arend WP. The innate immune system in rheumatoid arthritis. Arthritis Rheum 2001;44:2224-34.
2. Brennan FM, Foey AD, Feldmann M. The importance of T cell interactions with macrophages in rheumatoid cytokine production. Curr Top Microbiol Immunol 2006;305:177-94.
3. Firestein GS. Immunologic mechanisms in the pathogenesis of rheumatoid arthritis. J Clin Rheumatol 2005;11 Suppl:S39-44.
4. Zwerina J, Redlich K, Schett G, Smolen JS. Pathogenesis of rheumatoid arthritis: targeting cytokines. Ann NY Acad Sci 2005;1051:716-29.
5. Hamilton JA. Hypothesis: in vitro evidence for the invasive and tumor-like properties of the rheumatoid pannus. J Rheumatol 1983;10:845-51.
6. Harris ED Jr. Rheumatoid arthritis. Pathophysiology and implications for therapy. N Engl J Med 1990;322:1277-89.
7. Nishioka K, Hasunuma T, Kato T, Sumida T, Kobata T. Apoptosis in rheumatoid arthritis: a novel pathway in the regulation of synovial tissue. Arthritis Rheum 1998;41:1-9.
8. Hasunuma T, Kato T, Kobata T, Nishioka K. Molecular mechanism of immune response, synovial proliferation and apoptosis in rheumatoid arthritis. Springer Semin Immunopathol 1998;20:41-52.
9. Alvaro T, Lejeune M, Salvado MT, et al. Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells. Clin Cancer Res 2005;11:1467-73.
10. Tak PP, Spaeny-Dekking L, Kraan MC, Breedveld FC, Froelich CJ, Hack CE. The levels of soluble granzyme A and B are elevated in plasma and synovial fluid of patients with rheumatoid arthritis. Clin Exp Immunol 1999;116:366-70.
11. de Vries JF, von dem Borne PA, van Luxemburg-Heijs SA, et al. Differential activation of the death receptor pathway in human target cells induced by cytotoxic T lymphocytes showing different kinetics of killing. Haematologica 2007;92:1671-8.
12. Fox RI, Fong S, Sabharwal N, Carstens SA, Kung PC, Vaughan JH. Synovial fluid lymphocytes differ from peripheral blood lymphocytes in patients with rheumatoid arthritis. J Immunol 1982;128:351-4.
13. Kingsley G, Panayi G, Lanchbury J. Immunotherapy of rheumatic diseases - practice and prospects. Immunol Today 1991;12:177-9.
14. Belfrage H, Bhiladvala P, Hedlund G, Dohlsten M, Kalland T. Combined activation of murine lymphocytes with staphylococcal enterotoxin and interleukin-2 results in additive cytotoxic activity. Cancer Immunol Immunother 1994;38:265-71.
15. Griffiths GM, Alpert S, Lambert E, McGuire J, Weissman IL. Perforin and granzyme A expression identifying cytolytic lymphocytes in rheumatoid arthritis. Proc Natl Acad Sci USA 1992;89:549-53.
16. Ehrenstein MR, Evans JG, Singh A, et al. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNF-alpha therapy. J Exp Med 2004;200:277-85.
17. Strand S, Hofmann WJ, Hug H, et al. Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells - a mechanism of immune evasion? Nat Med 1996;2:1361-6.
18. Nakashima M, Sonoda K, Watanabe T. Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1. Nat Med 1999;5:938-42.
19. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
20. Sonoda K, Nakashima M, Kaku T, Kamura T, Nakano H, Watanabe T. A novel tumor-associated antigen expressed in human uterine and ovarian carcinomas. Cancer 1996;77:1501-9.
21. O'Sullivan JB, Cathcart ES. The prevalence of rheumatoid arthritis. Follow-up evaluation of the effect of criteria on rates in Sudbury, Massachusetts. Ann Intern Med 1972;76:573-7.
22. Feigenbaum SL, Masi AT, Kaplan SB. Prognosis in rheumatoid arthritis. A longitudinal study of newly diagnosed younger adult patients. Am J Med 1979;66:377-84.
23. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003;299:1057-61.
24. Aoki T, Inoue S, Imamura H, et al. EBAG9/RCAS1 expression in hepatocellular carcinoma: correlation with tumour dedifferentiation and proliferation. Eur J Cancer 2003;39:1552-61.
25. Ito Y, Yoshida H, Nakano K, et al. Overexpression of human tumor-associated antigen, RCAS1, is significantly linked to dedifferentiation of thyroid carcinoma. Oncology 2003;64:83-9.
26. Takahashi S, Urano T, Tsuchiya F, et al. EBAG9/RCAS1 expression and its prognostic significance in prostatic cancer. Int J Cancer 2003;106:310-5.
27. Kubokawa M, Nakashima M, Yao T, et al. Aberrant intracellular localization of RCAS1 is associated with tumor progression of gastric cancer. Int J Oncol 2001;19:695-700.
28. Nakamura Y, Yamazaki K, Oizumi S, et al. Expression of RCAS1 in human gastric carcinoma: a potential mechanism of immune escape. Cancer Sci 2004;95:260-5.
29. Izumi M, Nakanishi Y, Yoshino I, Nakashima M, Watanabe T, Hara N. Expression of tumor-associated antigen RCAS1 correlates significantly with poor prognosis in nonsmall cell lung carcinoma. Cancer 2001;92:446-51.
30. Ohshima K, Nakashima M, Sonoda K, Kikuchi M, Watanabe T. Expression of RCAS1 and FasL in human trophoblasts and uterine glands during pregnancy: the possible role in immune privilege. Clin Exp Immunol 2001;123:481-6.